Veralox

Veralox Therapeutics

This company develops small molecule therapeutics targeting 12-lipoxygenase to treat patients with heparin-induced thrombocytopenia and other immune-inflammatory diseases.

Promakhos Therapeutics

This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.

Veratx

The company develops medicines for patients with autoimmune diseases, focusing on the treatment of kidney conditions such as IgA nephropathy.

IMMvention Therapeutics

This biotechnology firm develops small molecule oral therapies for patients with sickle cell disease and other inflammatory or neurodegenerative conditions.

Promakhos

This company develops oral small-molecule immunotherapies that restore immune system function to treat patients with chronic inflammatory diseases.

Nilo Therapeuti

This biotechnology company develops medicines that target neural circuits to treat patients with autoimmune and inflammatory diseases.

Galecto

This biotechnology company develops small molecule therapeutics targeting galectin-3 and LOXL2 to treat patients with fibrosis, inflammation and cancer.

Velorum Therapeutics

This company develops heme-sequestering biologic drugs for patients with lung cancer, rare genetic porphyrias and heme-induced tissue injuries.